HomeCompareHBMBF vs ORCC

HBMBF vs ORCC: Dividend Comparison 2026

HBMBF yields 3.51% · ORCC yields 9.79%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HBMBF wins by $3.7K in total portfolio value· pulled ahead in Year 3
10 years
HBMBF
HBMBF
● Live price
3.51%
Share price
$268.61
Annual div
$9.44
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.1K
Annual income
$440.62
Full HBMBF calculator →
ORCC
ORCC
● Live price
9.79%
Share price
$13.48
Annual div
$1.32
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$21.4K
Annual income
$1.04
Full ORCC calculator →

Portfolio growth — HBMBF vs ORCC

📍 HBMBF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHBMBFORCC
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HBMBF + ORCC cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HBMBF pays
ORCC pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HBMBF
Annual income on $10K today (after 15% tax)
$298.75/yr
After 10yr DRIP, annual income (after tax)
$374.53/yr
ORCC
Annual income on $10K today (after 15% tax)
$832.34/yr
After 10yr DRIP, annual income (after tax)
$0.88/yr
At 15% tax rate, HBMBF beats the other by $373.64/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HBMBF + ORCC for your $10,000?

HBMBF: 50%ORCC: 50%
100% ORCC50/50100% HBMBF
Portfolio after 10yr
$23.3K
Annual income
$220.83/yr
Blended yield
0.95%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on ORCC right now

HBMBF
No analyst data
ORCC
Analyst Ratings
9
Buy
4
Hold
1
Sell
Consensus: Buy
Price Target
$16.00
+18.7% upside vs current
Range: $16.00 — $16.00
Altman Z
0.5
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HBMBF buys
0
ORCC buys
0
No recent congressional trades found for HBMBF or ORCC in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHBMBFORCC
Forward yield3.51%9.79%
Annual dividend / share$9.44$1.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%-50%
Portfolio after 10y$25.1K$21.4K
Annual income after 10y$440.62$1.04
Total dividends collected$4.0K$1.0K
Payment frequencyquarterlyquarterly
SectorStockBDC

Year-by-year: HBMBF vs ORCC ($10,000, DRIP)

YearHBMBF PortfolioHBMBF Income/yrORCC PortfolioORCC Income/yrGap
1$11,051$351.48$11,190$489.61$139.00ORCC
2$12,188$363.02$12,229$256.01$41.00ORCC
3← crossover$13,415$374.17$13,216$130.74+$199.00HBMBF
4$14,739$384.90$14,207$66.02+$532.00HBMBF
5$16,166$395.22$15,234$33.17+$932.00HBMBF
6$17,703$405.13$16,317$16.62+$1.4KHBMBF
7$19,357$414.61$17,468$8.32+$1.9KHBMBF
8$21,136$423.69$18,695$4.16+$2.4KHBMBF
9$23,048$432.36$20,006$2.08+$3.0KHBMBF
10$25,101$440.62$21,407$1.04+$3.7KHBMBF

HBMBF vs ORCC: Complete Analysis 2026

HBMBFStock

HBM Healthcare Investments AG specializes in fund of funds and direct investments in middle market and mature companies. The fund prefers to invest in start up, early stage, mid stage, mid venture, late venture, and late stage private companies, unlisted emerging companies, small cap public companies, buyouts, growth capital, and private investment in public equities (PIPES). Within fund of funds, it invests in venture capital funds. It also seeks to finance spin-offs of product lines or departments from larger corporations and the expansion or restructuring of established companies, seed stages, venture capital, expansion capital stages, spin-offs, and buyouts. The fund prefers to invest in the private and public companies in the healthcare sector with a focus on human medicine, drugs, pharma , biopharma, biotechnology, diagnostics, medical technology, and related industries. It seeks to make initial investments in companies whose primary products are in clinical development or the immediately preceding stage. The fund typically invests globally with a focus on Asia Pacific, Asia, North America, and Europe. In case of public companies, it focuses on those which originate from its private portfolio. The fund increases its investment in portfolio companies by participating in a follow-on financing or after the portfolio company's IPO. It may acquire majority participations in portfolio companies, usually takes a seat on the portfolio company's Board of Directors, and largely makes equity investments but may also invest through other instruments including convertible bonds, debt securities, structured products, and derivatives. The fund exits its portfolio companies through trade sale or IPO.

Full HBMBF Calculator →

ORCCBDC

Owl Rock Capital Corporation is a business development company. The fund makes investments in senior secured or unsecured loans, subordinated loans or mezzanine loans and also considers equity-related securities including warrants and preferred stocks also pursues preferred equity investments and common equity investments. Within private equity, it seeks to invest in growth, acquisitions, market or product expansion, refinancings and recapitalizations. It seeks to invest in middle market companies based in the United States, with EBITDA between $10 million and $250 million annually and/or annual revenue of $50 million and $2.5 billion at the time of investment.

Full ORCC Calculator →
📬

Get this HBMBF vs ORCC comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HBMBF vs SCHDHBMBF vs JEPIHBMBF vs OHBMBF vs KOHBMBF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.